PharVision Advisers’s 1st Source SRCE Stock Holding History

PharVision Advisers’s Portfolio SRCE Stock Details SRCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,679	Closed	-$226K	–	986
2025 Q3	$226K	Buy	+3,679	New	+$231K	0.13%	405

Other funds holding SRCE

1SB

1ST Source Bank South Bend, Indiana $2.21B AUM 28.75% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

PharVision Advisers's SRCE Position: Q4 2025 in Review

PharVision Advisers sold out of 1st Source (SRCE) in Q4 2025, closing a stake of 3,679 shares — an estimated $226K sold.

PharVision Advisers first reported a position in SRCE in Q3 2025 and held it in 1 quarter. The position peaked at $226K in Q3 2025. 197 funds tracked by Wall St. Rank hold SRCE as of Q4 2025.

PharVision Advisers reported no remaining 1st Source position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 3,679 1st Source shares in Q4 2025, an estimated $226K.
PharVision Advisers first reported a position in 1st Source in Q3 2025 and held it in 1 quarter.
PharVision Advisers's 1st Source position peaked at $226K in Q3 2025.
197 funds tracked by Wall St. Rank held 1st Source as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.